Midgard Science
A

Asymbio

Jinshan, China asymbio.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

AsymBio is a biologics CDMO based in Shanghai that provides development, manufacturing, quality control, and regulatory services for antibodies, recombinant biotherapeutics, bioconjugates, plasmids, and mRNAs. It serves global biopharmaceutical clients across early research, process development, toxicology batches, clinical batches, and commercial-scale manufacturing.

Services

  • Developability Assessment

    Assesses developability for biologic drug candidates.

  • Antibodies & Recombinant Biotherapeutics

    Provides cell line construction and development, upstream and downstream process development, drug substance and drug product development and manufacturing, release testing, and related services for antibodies and recombinant biotherapeutics.

    CDMO: development & manufacturing

  • Bioconjugates

    Provides payload-linker CMC services, antibody intermediate manufacturing, process development, drug product development, drug substance manufacturing, drug product manufacturing, and release testing for bioconjugates.

    CDMO: development & manufacturing

  • mRNA

    Provides plasmid linearization, in vitro mRNA transcription process development, mRNA-LNP process development, mRNA production, and mRNA release testing.

    CDMO: development & manufacturing

  • Analytical Science & Quality Control

    Provides physicochemical analysis, mass spectrometry analysis, bioassay release testing, and stability studies.

  • Regulatory Affairs

    Provides regulatory support services for biopharmaceutical development.

Turnaround
  • 3 to 5 months lead time for IND filing package
  • 7 weeks

Capabilities

Assays and studies
  • Antibodies
  • Process development
  • mRNA
  • ADCs
  • Toxicology
  • LNP
8 more
  • Stability studies
  • Lyophilization
  • Analytical development
  • Physicochemical analysis
  • Mass spectrometry analysis
  • Bioassay release testing
  • Developability assessment
  • Analytical method development
Scale and capacity
  • 50+ IND projects
  • 10+ NDA projects
  • 30+ payload-linker projects in parallel
  • 3–5 months lead time for IND filing package
  • Approximately 20+ cGMP audits since 2021

Instruments and platforms

  • Rigid isolators
  • Reaction vessels 5–1000L
  • Purification equipment
  • Lyophilizer
  • Nanofiltration
  • Ultrafiltration
  • Pressure filtration
  • Rotary steaming separation and purification equipment

Modalities and species

Modalities
  • Antibody
  • Bispecific
  • ADC
  • mRNA
  • Viral vector
  • Plasmid DNA
  • LNP / formulation

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: passed approximately 20+ customer audits since 2021

Details

Type
CRDMO
Address
518 Haoye Road, 4th floor, Jinshan Industrial Zone, Shanghai
Sites
Shanghai, China
Serves
Global

Public records

Parent company
Asymbio Holding B.V. · NL GLEIF

Similar labs